Matthew Taylor analyst JEFFERIES

Currently out of the existing stock ratings of Matthew Taylor, 121 are a BUY (59.9%), 64 are a HOLD (31.68%), 17 are a SELL (8.42%).

Matthew Taylor

Work Performance Price Targets & Ratings Chart

Analyst Matthew Taylor, currently employed at JEFFERIES, carries an average stock price target met ratio of 68.43% that have a potential upside of 18.03% achieved within 174 days.

Matthew Taylor’s has documented 389 price targets and ratings displayed on 36 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ABT, Abbott Laboratories at 17-Jul-2025.

Wall Street Analyst Matthew Taylor

Analyst best performing recommendations are on TNDM (TANDEM DIABETES CARE).
The best stock recommendation documented was for TNDM (TANDEM DIABETES CARE) at 11/27/2018. The price target of $36 was fulfilled within 2 days with a profit of $2.71 (8.14%) receiving and performance score of 40.7.

Average potential price target upside

ABT Abbott Laboratories BAX Baxter International BDX Becton Dickinson and Company DXCM DexCom EW Edwards Lifesciences Corp GMED Globus Medical INMD InMode Ltd ISRG Intuitive Surgical MASI Masimo MDT Medtronic PLC NUVA NuVasive PHG Koninklijke Philips NV ADR TFX Teleflex UTRS Minerva Surgical VAR Varian Medical Systems LIVN LivaNova PLC PODD Insulet RMD ResMed IART Integra LifeSciences Holdings NVRO Nevro Corp TNDM Tandem Diabetes Care ZBH Zimmer Biomet Holdings SYK Stryker ATEC Alphatec Holdings BSX Boston Scientific Corp AXNX Axonics Modulation Technologies PEN Penumbra CNMD CONMED HRC Hill-Rom Holdings ESTA Establishment Labs Holdings SENS Senseonics Holdings SIBN Si-Bone VREX Varex Imaging Corp NARI Inari Medical  GEHC GE HealthCare Technologies RWLK Rewalk Robotics Ltd

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$162

$35.15 (27.71%)

$159

14 days ago
(16-Oct-2025)

18/25 (72%)

$33.46 (26.03%)

499

Buy

$142

$15.15 (11.94%)

$144

15 days ago
(15-Oct-2025)

7/11 (63.64%)

$14.37 (11.26%)

317

Buy

$146

$19.15 (15.10%)

$141

15 days ago
(15-Oct-2025)

18/23 (78.26%)

$18.37 (14.39%)

376

Buy

$145

$18.15 (14.31%)

$137

3 months 13 days ago
(17-Jul-2025)

13/14 (92.86%)

$21.33 (17.25%)

369

Buy

$145

$18.15 (14.31%)

$139

3 months 13 days ago
(17-Jul-2025)

6/9 (66.67%)

$21.33 (17.25%)

753

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Matthew Taylor is most bullish on?

Potential upside of $18.15 has been obtained for ABT (ABBOTT LABORATORIES)

What Year was the first public recommendation made by Matthew Taylor?

On 2010

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?